688389.SH
普门科技
SSE · Healthcare · Medical - Specialties · CN
CNY 10.80
−3.23%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.1B | 1.0B | 1.1B | 1.1B | 983.0M |
| Cost of Revenue | 407.9M | 381.9M | 376.5M | 424.0M | 407.8M |
| Gross Profit | 675.0M | 656.0M | 771.6M | 721.8M | 575.3M |
| Operating Expenses | |||||
| R&D Expense | 238.0M | 228.6M | 201.5M | 172.7M | 170.8M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 75.5M | 73.5M | 69.0M | 54.8M | 45.9M |
| Selling & Marketing Expense | 191.8M | 186.4M | 152.8M | 165.7M | 147.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 519.9M | 484.8M | 393.8M | 375.0M | 338.3M |
| Cost and Expenses | 927.7M | 866.7M | 770.3M | 798.9M | 746.1M |
| Operating Income (EBIT) | 159.8M | 179.2M | 377.7M | 345.0M | 256.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 161.1M | 180.3M | 379.4M | 344.5M | 256.5M |
| Income Tax Expense | 3.0M | 1.5M | 36.5M | 17.0M | 5.3M |
| Bottom Line | |||||
| Net Income | 163.0M | 184.2M | 345.4M | 328.6M | 251.5M |
| Earnings from Cont. Ops | 158.1M | 178.8M | 343.0M | 327.5M | 251.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 163.0M | 184.2M | 345.4M | 328.6M | 251.5M |
| Per Share | |||||
| Basic EPS | CN¥0.38 | CN¥0.43 | CN¥0.81 | CN¥0.77 | CN¥0.60 |
| Diluted EPS | CN¥0.38 | CN¥0.43 | CN¥0.81 | CN¥0.77 | CN¥0.60 |
| Revenue Per Share | CN¥2.67 | CN¥2.42 | CN¥2.69 | CN¥2.68 | CN¥2.35 |
| Shares | |||||
| Basic Shares Outstanding | 406.1M | 428.4M | 426.4M | 426.7M | 419.1M |
| Diluted Shares Outstanding | 406.1M | 428.4M | 426.4M | 426.7M | 419.1M |
| Profitability Metrics | |||||
| EBITDA | — | 219.4M | 414.7M | 374.3M | 280.3M |
| D&A | — | 40.1M | 37.1M | 29.2M | 23.9M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026